Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MBS ETF (MBB) vs Xylem, Inc. (XYL) Price & Performance

iShares MBS ETFTrade
Xylem, Inc.Trade

Price performance (Past 24H)

Key statistics

iShares MBS ETF vs Xylem, Inc. — how do they compare? iShares MBS ETF trades at $89.69 (market cap $35.41B), while Xylem, Inc. trades at $102.22 (market cap $23.81B). The key difference: iShares MBS ETF is the larger of the two by market cap, and Xylem, Inc. pays a 1.69% dividend while iShares MBS ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares MBS ETF for 96 Days and Xylem, Inc. for 50 Days on average.

MBBXYL
Market Cap
$35.41B$23.81B
Volume
5,388,5252,234,713
Sector
Fixed IncomeIndustrials
52-Week High
$96.91$152.95
52-Week Low
$89.09$100.92
Typical Hold Time
96 Days50 Days
Enterprise Value
—$25.59B
Dividend Yield
—1.69%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MBS ETF

MBB, the iShares MBS ETF, trades at $89.54, up 0.36% on the day but showing a bearish technical signal overall. The ETF has faced significant short interest growth of 98.3% in September 2026, reaching 6.57 million shares, and recently hit a 52-week low. Recent news highlights concerns over intermediate duration risk amid potential rate hikes, though institutional buying from firms like Corient Private Wealth and Baird Financial Group provides some support. Key technical indicators show oversold conditions on the 12-day RSI but strong selling pressure from moving averages.

The outlook for MBB remains cautious due to interest rate sensitivity and convexity risks in the mortgage-backed securities market. While dividend payments offer income, rising rates and inflation pressures pose downside risks. Analyst sentiment is neutral to bearish, with the ETF's performance heavily tied to Federal Reserve policy. Investors should weigh the high yield against duration risk in a tightening cycle.

Xylem, Inc.

XYL trades at $101.83, down 2.63% today, with a bearish technical signal from moving averages. The company shows strong fundamentals with consistent revenue growth from $5.5B in 2022 to $9.0B in 2025 and net income margin expanding to 10.59%. Recent acquisitions of Cornell Pump and Roper Pump strengthen its industrial water solutions portfolio. XYL has beaten earnings estimates for three consecutive quarters, with Q3 2026 results expected on October 27, 2026.

Analyst consensus is mixed with 47.5% buy ratings and a $149.13 price target suggesting 46% upside. Key risks include China market weakness and increased debt from recent acquisitions. The stock offers value with reasonable P/E of 24.28 and strong cash flow generation, though technical indicators suggest near-term caution.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MBB
100% Buy0% Sell
Avg holding period · 96 Days
XYL
100% Buy0% Sell
Avg holding period · 50 Days

Top news

Latest headlines on both assets

About iShares MBS ETF

The fund will invest at least 80% of its assets in the component securities of the underlying index and TBAs that have economic characteristics that are substantially identical to the economic characteristics of the component securities of the index, and the fund will invest at least 90% of its assets in fixed income securities included in the underlying index that advisor believes will help the fund track the index.

Read more on MBB →

About Xylem, Inc.

Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.

Read more on XYL →